Yuan-chin Hsieh
Kaohsiung, KHQ 82400, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Integrin α5β1 Activation by PHSRN Peptide Elicits Neuroprotection and Functional Recovery in Parkinson's Disease Mice.
Journal: Antioxidants (Basel, Switzerland)
Published: May 05, 2026
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse events.
Journal: International journal of biological macromolecules
Published: October 27, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunization.
Journal: NPJ vaccines
Published: May 28, 2025
Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo.
Journal: Biomaterials research
Published: August 07, 2024
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis.
A lesion-selective albumin-CTLA4Ig as a safe and effective treatment for collagen-induced arthritis.
Journal: Inflammation and regeneration
Published: November 14, 2022
ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells.
Journal: Cancers
Published: July 11, 2022
Micro-PET imaging of hepatitis C virus NS3/4A protease activity using a protease-activatable retention probe.
Journal: Frontiers in microbiology
Published: March 15, 2022
A universal in silico V(D)J recombination strategy for developing humanized monoclonal antibodies.
Journal: Journal of nanobiotechnology
Published: October 14, 2021
Bispecific antibody (HER2 × mPEG) enhances anti-cancer effects by precise targeting and accumulation of mPEGylated liposomes.
Journal: Acta biomaterialia
Published: October 25, 2019
Enhanced drug internalization and therapeutic efficacy of PEGylated nanoparticles by one-step formulation with anti-mPEG bispecific antibody in intrinsic drug-resistant breast cancer.
Journal: Biomaterials science
Published: June 29, 2019
Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein.
Journal: Scientific reports
Published: October 05, 2018
Last Updated: 09/26/2026